跳至主要内容
临床试验/NCT04163484
NCT04163484已完成不适用

Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease

I.M. Sechenov First Moscow State Medical University1 个研究点 分布在 1 个国家目标入组 156 人开始时间: 2019年1月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
156
试验地点
1
主要终点
Contrast associated acute kidney injury

研究概览

简要总结

The goal of the study is to assess the prevalence of contrast-associated acute kidney injury in patients with stable coronary artery disease, ST-elevation myocardial infarction and unstable angina/NSTEMI, assess the risk factors of contrast-induced acute kidney injury development and the influence of contrast-induced kidney injury on 1-year prognosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females aged 18-80
  • Stable CAD receiving optimal medical treatment requiring PCI or STEMI or NSTEMI
  • Intra-arterial injection of iodinated contrast media
  • Informed consent

排除标准

  • Age less than 18
  • Pregnancy, lactation
  • Refuse to sign the informed consent
  • Contraindications for PCI
  • Other conditions affecting prognosis (oncology, liver failure etc)
  • CKD stage 4-5
  • Patients receiving nephrotoxic drugs

结局指标

主要结局

Contrast associated acute kidney injury

时间窗: 48-72 hours

Number of patients with contrast associated kidney injury after contrast exposure

次要结局

  • Overall mortality(1 year)
  • Repeat hospitalisation(1 year)
  • Stroke(1 year)
  • New-onset dialysis(1 year)
  • Cardiovascular mortality(1 year)
  • Myocardial infarction(1 year)
  • Repeat revascularization(1 year)
  • Acute decompensation of heart failure(1 year)
  • Chronic kidney disease progression(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Olga Mironova

MD PhD Associate Professor

I.M. Sechenov First Moscow State Medical University

研究点 (1)

Loading locations...

相似试验